Amneal Pharmaceuticals (AMRX) Return on Equity (2018 - 2026)

Amneal Pharmaceuticals' Return on Equity history runs 9 years deep, the most recent figure standing at 0.03% for Q1 2026.

• In Q1 2026, Return on Equity fell 3.0% year-over-year to 0.03%; the TTM figure through Mar 2026 stood at 0.03% (down 3.0% YoY), while the FY2025 annual figure was 0.01%, down 3.0% from the prior year.
• Return on Equity was 0.03% for Q1 2026 at Amneal Pharmaceuticals, down from 0.01% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.06% in Q1 2024 to a low of 0.03% in Q1 2026.
• Historically, Return on Equity has averaged 0.0% across 5 years, with a median of 0.0% in 2025.
• The sharpest annual moves came in 2024 and 2025: Return on Equity increased 7 bps in 2024, then declined 6 bps in 2025.
• A 5-year view of Return on Equity shows it stood at 0.01% in 2022, then jumped by 58 bps to 0.01% in 2023, then soared by 230 bps to 0.01% in 2024, then sank by 295 bps to 0.01% in 2025, then plunged by 120 bps to 0.03% in 2026.
• The last three Return on Equity figures came in at 0.03% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.